drugset / Trial / NCT06297642
TQB2928 Injection Combined With Penpulimab in Treatment of Advanced Malignant Tumors.
NaSingle-groupOpen-labelTreatment
Summary
This study will evaluate the safety and efficiency of TQB2928 injection combined with Penpulimab in the treatment of patients with advanced malignant tumors.
Timeline
- Start
- 2024-05-24
- Primary completion
- 2024-07-31
- Completion
- 2024-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Penpulimab | Monoclonal antibody | — | — |
| Subject | TQB2928 | Monoclonal antibody | — | — |